p53 mutations in all stages of thyroid carcinomas
Author:
- M. ZouMZM. Zou
- 1 October 1993
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 77 (4) , 1054-1058
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53Science, 1990
- WILD-TYPE HUMAN P53 IS ANTIPROLIFERATIVE IN SV40-TRANSFORMED HAMSTER-CELLS1990
- Wild-type p53 can inhibit oncogene-mediated focus formation.Proceedings of the National Academy of Sciences, 1989
- Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactionGenomics, 1989
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989
- Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformationJournal of Virology, 1989
- METH-A FIBRO-SARCOMA CELLS EXPRESS 2 TRANSFORMING MUTANT P53 SPECIES1988
- IMMORTALIZATION OF RAT EMBRYO FIBROBLASTS BY THE CELLULAR P53 ONCOGENE1988
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988